Â¥
6.49
Oct 16
Business Description
Tecon Biology Co Ltd
NAICS : 111998
ISIN : CNE000001PZ9
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.95 | |||||
Debt-to-EBITDA | -12.7 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.87 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.1 | |||||
3-Year Book Growth Rate | -6.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.71 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.52 | |||||
9-Day RSI | 50.72 | |||||
14-Day RSI | 51.25 | |||||
6-1 Month Momentum % | -6.64 | |||||
12-1 Month Momentum % | -12.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 95.1 | |||||
Days Sales Outstanding | 13.02 | |||||
Days Payable | 13.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 3.2 | |||||
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | 12.7 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.56 | |||||
Operating Margin % | -0.58 | |||||
Net Margin % | -3.54 | |||||
FCF Margin % | -0.45 | |||||
ROE % | -9.45 | |||||
ROA % | -3.73 | |||||
ROIC % | -0.84 | |||||
ROC (Joel Greenblatt) % | -4.77 | |||||
ROCE % | -4.65 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 9.62 | |||||
Shiller PE Ratio | 24.04 | |||||
PS Ratio | 0.49 | |||||
PB Ratio | 1.34 | |||||
Price-to-Tangible-Book | 1.47 | |||||
Price-to-Operating-Cash-Flow | 10.51 | |||||
EV-to-EBIT | -24.87 | |||||
EV-to-EBITDA | -24.87 | |||||
EV-to-Revenue | 0.68 | |||||
EV-to-FCF | -152.09 | |||||
Price-to-Median-PS-Value | 0.34 | |||||
Earnings Yield (Greenblatt) % | -4.02 | |||||
FCF Yield % | -0.92 | |||||
Forward Rate of Return (Yacktman) % | 15.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tecon Biology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 18,055.7 | ||
EPS (TTM) (Â¥) | -0.48 | ||
Beta | 0.88 | ||
Volatility % | 34.78 | ||
14-Day RSI | 51.25 | ||
14-Day ATR (Â¥) | 0.286484 | ||
20-Day SMA (Â¥) | 6.308 | ||
12-1 Month Momentum % | -12.57 | ||
52-Week Range (Â¥) | 5.67 - 9.08 | ||
Shares Outstanding (Mil) | 1,365.25 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tecon Biology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tecon Biology Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Tecon Biology Co Ltd Frequently Asked Questions
What is Tecon Biology Co Ltd(SZSE:002100)'s stock price today?
When is next earnings date of Tecon Biology Co Ltd(SZSE:002100)?
Does Tecon Biology Co Ltd(SZSE:002100) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |